Critical analysis of antibacterial agents in clinical development

Nature Reviews. Microbiology
Ursula TheuretzbacherGuy E Thwaites

Abstract

The antibacterial agents currently in clinical development are predominantly derivatives of well-established antibiotic classes and were selected to address the class-specific resistance mechanisms and determinants that were known at the time of their discovery. Many of these agents aim to target the antibiotic-resistant priority pathogens listed by the WHO, including Gram-negative bacteria in the critical priority category, such as carbapenem-resistant Acinetobacter, Pseudomonas and Enterobacterales. Although some current compounds in the pipeline have exhibited increased susceptibility rates in surveillance studies that depend on geography, pre-existing cross-resistance both within and across antibacterial classes limits the activity of many of the new agents against the most extensively drug-resistant (XDR) and pan-drug-resistant (PDR) Gram-negative pathogens. In particular, cross-resistance to unrelated classes may occur by co-selection of resistant strains, thus leading to the rapid emergence and subsequent spread of resistance. There is a continued need for innovation and new-class antibacterial agents in order to provide effective therapeutic options against infections specifically caused by XDR and PDR Gram-negative bac...Continue Reading

References

Apr 2, 2004·Journal of Medicinal Chemistry·Abedawn I KhalafColin J Suckling
Nov 19, 2008·Antimicrobial Agents and Chemotherapy·Louis S GreenThale C Jarvis
Oct 29, 2009·Cellular and Molecular Life Sciences : CMLS·Maulik ThakerGerard D Wright
Nov 17, 2010·The Journal of Antimicrobial Chemotherapy·D M LivermoreN Woodford
Mar 2, 2011·Antimicrobial Agents and Chemotherapy·Gabriel CabotUNKNOWN Spanish Network for Research in Infectious Diseases (REIPI)
Aug 10, 2011·Antimicrobial Agents and Chemotherapy·S EscaichC Soulama-Mouze
Nov 10, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A CaponeN Petrosillo
Apr 29, 2014·The Lancet Infectious Diseases·Jason A RobertsUNKNOWN International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the Europe
Nov 21, 2015·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Kitaw NegashMay Ho
Mar 19, 2016·Cold Spring Harbor Perspectives in Medicine·Trudy H Grossman
Nov 22, 2016·The Lancet Infectious Diseases·Hajo GrundmannUNKNOWN European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group
May 10, 2017·Nature Chemical Biology·Jooyoung ParkNiraj H Tolia
May 24, 2017·Antimicrobial Agents and Chemotherapy·David CorbettTroy Lister
Jun 28, 2017·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·U Theuretzbacher
Aug 30, 2017·Antimicrobial Agents and Chemotherapy·Olga LomovskayaMichael N Dudley
Sep 7, 2017·Antimicrobial Agents and Chemotherapy·Ester Del Barrio-TofiñoAntonio Oliver
Nov 21, 2017·Current Opinion in Microbiology·Ursula Theuretzbacher
Dec 26, 2017·The Lancet Infectious Diseases·Evelina TacconelliUNKNOWN WHO Pathogens Priority List Working Group
Mar 22, 2018·International Journal of Antimicrobial Agents·Matthew E FalagasUNKNOWN Hellenic TP-6076 Study Group
Mar 23, 2018·The Journal of Antimicrobial Chemotherapy·Paolo GaibaniSimone Ambretti
Apr 5, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stephanie N TaylorEtienne F Dumont
May 22, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Gregory BalabanianJohn Quale
Jul 25, 2018·Antimicrobial Agents and Chemotherapy·Johanne BlaisFolkert Reck
Aug 1, 2018·Antimicrobial Agents and Chemotherapy·Karen Bush
Aug 26, 2018·Current Opinion in Pharmacology·M Daben J LibardoClifton E Barry
Oct 6, 2018·MedChemComm·Kamaleddin H M E Tehrani, Nathaniel I Martin
Oct 20, 2018·The Lancet Infectious Diseases·Ursula TheuretzbacherStephan Harbarth
Oct 24, 2018·The Journal of Antimicrobial Chemotherapy·David M Livermore
Nov 7, 2018·Antimicrobial Agents and Chemotherapy·James A KarlowskyGeorge G Zhanel

❮ Previous
Next ❯

Citations

Mar 25, 2020·JAMA : the Journal of the American Medical Association·Mo YinEli N Perencevich
May 4, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cornelius J Clancy, M Hong Nguyen
Jun 26, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John H Rex, Kevin Outterson
Sep 3, 2020·Pharmaceutics·Priya Dharshini KrishnanRene Kizek
Sep 12, 2020·Expert Opinion on Pharmacotherapy·Matteo BassettiDaniele Roberto Giacobbe
Aug 7, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cornelius J Clancy, M Hong Nguyen
Oct 1, 2020·Dalton Transactions : an International Journal of Inorganic Chemistry·Cheng Chen, Kewu Yang
May 2, 2020·Antibiotics·Paul S Hoffman
Jul 29, 2020·The Journal of Microbiology·Shivakumar S Jalde, Hyun Kyung Choi
Jun 26, 2020·Frontiers in Microbiology·Dirk EhmannBenjamin A H Jensen
Jul 19, 2020·The FEBS Journal·Huihui HanJianhua Wang
May 29, 2020·Emerging Topics in Life Sciences·Kim R Hardie
Nov 4, 2020·Future Microbiology·Matteo BassettiDaniele R Giacobbe
Nov 4, 2020·Expert Review of Anti-infective Therapy·Nicholas HemingDjillali Annane
Dec 15, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Katja BeckerUNKNOWN ENABLE consortium
Jan 15, 2021·Organic & Biomolecular Chemistry·Mahmud T MorshedAndrew M Piggott
Nov 9, 2020·Bioorganic & Medicinal Chemistry Letters·Martín S FaillaceWalter J Peláez
Jan 27, 2021·Chemical Society Reviews·Bo HanJun-Long Li
Feb 4, 2021·The Journal of Antimicrobial Chemotherapy·Ursula TheuretzbacherEvelina Tacconelli
Jul 29, 2020·Antimicrobial Agents and Chemotherapy·Madeline R GalacPatrick Mc Gann
Nov 13, 2020·Clinical Microbiology Reviews·Dafna YahavLeonard Leibovici
Nov 13, 2020·Advances in Pharmacological and Pharmaceutical Sciences·Satish JankieLexley Maureen Pinto Pereira
Nov 20, 2020·Open Forum Infectious Diseases·Cornelius J Clancy, M Hong Nguyen
Feb 18, 2021·Infectious Diseases and Therapy·Dafna YahavNoam Tau
Feb 23, 2021·Journal of Medicinal Chemistry·Dean G Brown, Heike J Wobst
Dec 30, 2020·Chemical Reviews·Jed F Fisher, Shahriar Mobashery
Apr 1, 2021·Accounts of Chemical Research·Maya A FarhaEric D Brown
Apr 4, 2021·International Journal of Molecular Sciences·Víctor Vinuesa, Michael J McConnell
May 7, 2021·Frontiers in Medicine·Chantal M MorelUNKNOWN Enhanced Surveillance Expert Consensus Group (CANSORT-SCI)
May 5, 2021·The Journal of Antimicrobial Chemotherapy·Mingju HaoLiang Chen
May 12, 2021·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Elena CarraraEvelina Tacconelli
Jun 23, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Kimberly CipkoPamela Konecny
Jul 3, 2021·Life·Roberto GiurazzaEmanuele Durante-Mangoni
Jul 6, 2021·JAC-antimicrobial Resistance·David M Livermore

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

The Lancet Infectious Diseases
Ursula TheuretzbacherStephan Harbarth
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
J VilaC Ballesté-Delpierre
© 2021 Meta ULC. All rights reserved